文献速递流行病学与生物统计

2009至2017年德国大学医学中心完成的临床试验中预设主要结局多次变更的频率:一项元研究

Frequency of multiple changes to prespecified primary outcomes of clinical trials completed between 2009 and 2017 in German university medical centers: A meta-research study.
PubMed 文献 · PLoS Med · 2023-10-31

该元研究分析了2009至2017年德国大学医学中心完成的1746项随机对照试验的注册记录变更史,并在292项随机子样本中评估注册记录与发表结果的一致性。55%的试验在试验过程中主要结局发生过变更,23%为重大变更,但仅1%的变更在发表论文中透明报告。最新注册版本与发表结果之间的主要结局差异见于41%的试验,其中18%为重大变更。

要点

  • 55%的试验在试验过程中主要结局发生过变更,23%为重大变更。
  • 41%的试验发表结果与最新注册版本的主要结局不一致,18%为重大变更。
  • 仅1%的发生变更的试验在发表论文中报告了变更。

核心结论

  • 55%的试验主要结局发生过变更,23%为重大变更,但极少在发表论文中透明报告,且常在最新注册版本中不可见。
  • 需要更多透明度,并通过对注册记录的深入分析使这些变更更容易被识别。

研究设计与样本

  • 分析2009至2017年德国大学医学中心完成的、注册于ClinicalTrials.gov或德国WHO初级注册库(德国临床试验注册库DRKS)的全部1746项随机对照试验的注册记录变更史,发表结果截至2022年,数据检索于2022年1月24日。
  • 在292项试验的随机子样本中评估注册记录与发表结果之间的差异。
  • 主要结局变更定义为在试验关键里程碑的不同注册版本之间、最新注册版本与结果发表之间,以及试验开始后发生但最新注册版本与发表之间无差异的变更。
  • 重大变更定义为主要结局增加、删除、改为次要结局,或次要结局改为主要结局。
  • 还评估了发表论文透明报告变更的比例及与变更相关的特征。

主要发现

  • 全部1746项试验中,23%(n=393)在试验开始至最新注册版本之间主要结局发生变更,8%(n=142)为重大变更。
  • 292项抽样试验中,41%(120项;95%CI [35%, 47%])的发表论文主要结局与最新注册版本不同,18%(54项;95%CI [14%, 23%])为重大变更。
  • 292项试验中,55%(161项;95%CI [49%, 61%])在试验过程中任一时间点主要结局发生变更,23%(67项;95%CI [18%, 28%])发生重大变更。
  • 仅注册记录内变更、最新注册版本与发表之间无明显差异者占14%(41/292;95%CI [10%, 19%]),其中4%(13/292;95%CI [2%, 7%])为重大变更。
  • 发生变更的161项试验中,仅1%(2项;95%CI [0%, 4%])在发表论文中报告了变更。

关键数值与推荐

  • 探索性逻辑回归分析显示,注册时间较近的试验出现注册记录差异的可能性较低(OR 0.74;95%CI [0.69, 0.80];p<0.001)。
  • 未在ClinicalTrials.gov注册的试验出现注册记录差异的可能性较低(OR 0.41;95%CI [0.23, 0.70];p=0.002)。
  • 非企业资助的试验出现注册记录差异的可能性较低(OR 0.29;95%CI [0.21, 0.41];p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 结局变更分类存在一定程度的主观性。
  • 仅纳入单一地理区域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical trial registries allow assessment of deviations of published trials from their protocol, which may indicate a considerable risk of bias. However, since entries in many registries can be updated at any time, deviations may go unnoticed. We aimed to assess the frequency of changes to primary outcomes in different historical versions of registry entries, and how often they would go unnoticed if only deviations between published trial reports and the most recent registry entry are assessed. METHODS AND FINDINGS: We analyzed the complete history of changes of registry entries in all 1746 randomized controlled trials completed at German university medical centers between 2009 and 2017, with published results up to 2022, that were registered in ClinicalTrials.gov or the German WHO primary registry (German Clinical Trials Register; DRKS). Data were retrieved on 24 January 2022. We assessed deviations between registry entries and publications in a random subsample of 292 trials. We determined changes of primary outcomes (1) between different versions of registry entries at key trial milestones, (2) between the latest registry entry version and the results publication, and (3) changes that occurred after trial start with no change between latest registry entry version and publication (so that assessing the full history of changes is required for detection of changes). We categorized changes as major if primary outcomes were added, dropped, changed to secondary outcomes, or secondary outcomes were turned into primary outcomes. We also assessed (4) the proportion of publications transparently reporting changes and (5) characteristics associated with changes. Of all 1746 trials, 23% (n = 393) had a primary outcome change between trial start and latest registry entry version, with 8% (n = 142) being major changes, that is, primary outcomes were added, dropped, changed to secondary outcomes, or secondary outcomes were turned into primary outcomes. Primary outcomes in publications were different from the latest registry entry version in 41% of trials (120 of the 292 sampled trials; 95% confidence interval (CI) [35%, 47%]), with major changes in 18% (54 of 292; 95% CI [14%, 23%]). Overall, 55% of trials (161 of 292; 95% CI [49%, 61%]) had primary outcome changes at any timepoint over the course of a trial, with 23% of trials (67 of 292; 95% CI [18%, 28%]) having major changes. Changes only within registry records, with no apparent discrepancy between latest registry entry version and publication, were observed in 14% of trials (41 of 292; 95% CI [10%, 19%]), with 4% (13 of 292; 95% CI [2%, 7%]) being major changes. One percent of trials with a change reported this in their publication (2 of 161 trials; 95% CI [0%, 4%]). An exploratory logistic regression analysis indicated that trials were less likely to have a discrepant registry entry if they were registered more recently (odds ratio (OR) 0.74; 95% CI [0.69, 0.80]; p<0.001), were not registered on ClinicalTrials.gov (OR 0.41; 95% CI [0.23, 0.70]; p = 0.002), or were not industry-sponsored (OR 0.29; 95% CI [0.21, 0.41]; p<0.001). Key limitations include some degree of subjectivity in the categorization of outcome changes and inclusion of a single geographic region. CONCLUSIONS: In this study, we observed that changes to primary outcomes occur in 55% of trials, with 23% trials having major changes. They are rarely transparently reported in the results publication and often not visible in the latest registry entry version. More transparency is needed, supported by deeper analysis of registry entries to make these changes more easily recognizable. Protocol registration: Open Science Framework (https://osf.io/t3qva; amendment in https://osf.io/qtd2b).

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Holst M, Haslberger M, Yerunkar S, et al. Frequency of multiple changes to prespecified primary outcomes of clinical trials completed between 2009 and 2017 in German university medical centers: A meta-research study. PLoS Med. 2023. PMID: 37906614. doi:10.1371/journal.pmed.1004306

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。